HEPATITIS D, CHRONIC
Clinical trials for HEPATITIS D, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS D, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS D, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against rare liver virus
Disease control OngoingThis study tests two experimental drugs, VIR-2218 and VIR-3434, in about 95 adults with chronic hepatitis D, a serious liver infection. The goal is to see if the drugs can lower the virus to undetectable levels and improve liver function. Participants must have had hepatitis D fo…
Matched conditions: HEPATITIS D, CHRONIC
Phase: PHASE2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Scientists hunt for clues to stop hepatitis drug without relapse
Knowledge-focused OngoingThis study aims to find biological markers that can tell doctors when it is safe for patients with chronic hepatitis delta to stop taking the drug bulevirtide without the virus coming back. Twenty adults with stable liver disease who have been on bulevirtide for at least 48 weeks…
Matched conditions: HEPATITIS D, CHRONIC
Phase: NA • Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated May 17, 2026 13:27 UTC